A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.

by Kyle Bagenstose

Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.

by Sandra Gordon

Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.

by Taneia Surles

Experts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.

by Thomas Celona

‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.

by Laura Gesualdi Gilmore

Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.

by Sandra Gordon

A survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.

by Cameron Walker

After a cancer diagnosis, people who are deaf or hard of hearing can struggle if accommodations don’t meet their communication needs.

by Eric Fitzsimmons

Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.

by Kyle Bagenstose

News coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.

by Laura Gesualdi Gilmore